ISSN: 1462-2416

Journal Home

Journal Guideline

Pharmacogenomics Q3 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Pharmacogenomics is a journal indexed in SJR in Genetics and Pharmacology with an H index of 103. It has an SJR impact factor of 0,516 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,516.

Pharmacogenomics focuses its scope in these topics and keywords: role, ga, hlab, memory, pharmacogenetics, pharmacogenomics, therapy, variation, addiction, administration, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Genetics (Q3) Molecular Medicine (Q3) Pharmacology (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,516

SJR Impact factor

103

H Index

58

Total Docs (Last Year)

295

Total Docs (3 years)

2546

Total Refs

533

Total Cites (3 years)

278

Citable Docs (3 years)

1.66

Cites/Doc (2 years)

43.9

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Cancer genetics Q3
BMC Medical Genomics Q3
Current Stem Cell Reports Q3
Epigenomics Q3
Molecular Genetics and Metabolism Reports Q3

Compare this journals

Aims and Scope

Best articles by citations

DxS Ltd

Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations

Lab-on-a-Chip and Microarrays: Discovery and Development

Bulletin Board

Predicting inductive drug-drug interactions

The 6th International Meeting on Single Nucleotide Polymorphism and Complex Genome Analysis

Digene Corporation

Genome-wide evaluation of the public SNP databases

A reality check for molecular diagnostics in clinical practice

Etiologics Ltd

Inventors and their attorneys must beware of their actions before the US Patent & Trademark Office

Candidate gene case-control studies

SHOW MORE ARTICLES

Implementation of pharmacogenetics in clinical practice is challenging

Regulatory options for pharmacogenetics

Differential Gene Expression 2002'

How to understand a complex reality: statistical issues in microarray experiments

The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer

Practical Bioinformatics

Predicting and diagnosing abacavir and nevirapine drug hypersensitivity: from bedside to bench and back again

Research Highlights: Revisiting the frontiers of pharmacogenomics of colon cancer

Immunogenetics and sleep disorders

CYP2A6polymorphisms and risk for tobacco-related cancers

deCODE genetics, Inc.

A systems approach towards an understanding, diagnosis and personalized treatment of autism spectrum disorders